Literature DB >> 7037100

Clomipramine and exposure for chronic obsessive-compulsive rituals: III. Two year follow-up and further findings.

D Mawson, I M Marks, L Ramm.   

Abstract

Forty chronic ritualizers were given clomipramine or placebo from weeks 0 to 36; also all had exposure in vivo, half from weeks 4 to 10 (30 hours) and half from weeks 7 to 10 (15 hours). In the 37 patients available at week 114 there were substantial and maintained improvements in rituals, mood and social adjustment compared to week 0. Reduction of rituals was even greater in those who had 30 hours of exposure. There was no drug effect on rituals at two year follow-up. Greater initial anxiety or depression predicted the superiority of clomipramine over placebo from weeks 10 to 36 and more prescription of tricyclics in follow-up. However, two years outcome was not predicted by initial anxiety or depression, nor by sex, age, age of onset nor duration of rituals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7037100     DOI: 10.1192/bjp.140.1.11

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  8 in total

1.  Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.

Authors:  Michael Rufer; Iver Hand; Heike Alsleben; Anne Braatz; Jürgen Ortmann; Birgit Katenkamp; Susanne Fricke; Helmut Peter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-12       Impact factor: 5.270

Review 2.  Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder.

Authors:  D McTavish; P Benfield
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

3.  A 2-year prospective follow-up study of the course of obsessive-compulsive disorder.

Authors:  Jane L Eisen; Anthony Pinto; Maria C Mancebo; Ingrid R Dyck; Maria E Orlando; Steven A Rasmussen
Journal:  J Clin Psychiatry       Date:  2010-08       Impact factor: 4.384

4.  Drug treatment of obsessive-compulsive disorder.

Authors:  P T Lelliott; W O Monteiro
Journal:  Drugs       Date:  1986-01       Impact factor: 9.546

5.  Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects.

Authors:  Y Kasvikis; I M Marks
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

6.  Subtyping obsessive compulsive patients by depressive symptoms: a retrospective pilot study.

Authors:  L L Tynes; D K Winstead
Journal:  Psychiatr Q       Date:  1999

7.  A time-limited behavioral group for treatment of obsessive-compulsive disorder.

Authors:  B L Van Noppen; M T Pato; R Marsland; S A Rasmussen
Journal:  J Psychother Pract Res       Date:  1998

8.  Quality of life changes following inpatient and outpatient treatment in obsessive-compulsive disorder: a study with 12 months follow-up.

Authors:  Elisabeth Hertenstein; Nicola Thiel; Nirmal Herbst; Tobias Freyer; Christoph Nissen; Anne Katrin Külz; Ulrich Voderholzer
Journal:  Ann Gen Psychiatry       Date:  2013-02-22       Impact factor: 3.455

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.